Market Access Challenges for Innovative Cancer Treatments in the Nordic Region

Market Access Challenges for Innovative Cancer Treatments in the Nordic Region

Reproduced from IMS’ publication: “Pharma Pricing and Reimbursement” (PPR), January 2014

At SMI’s European Pharmaceutical Pricing and Reimbursement Conference in London, in October 2013, Peter Hertzman offered his perspective on the challenges faced by manufacturers attempting to achieve access to new, innovative oncology products in the Nordic region. Following the meeting, he spoke to Mick Maroney at IMS’ PPR. Peter Hertzman said that: “It looks like in the future more flexibility will be required in terms of contracts and pricing. The industry will have to play a proactive role”.